Reperfusion Injury

Reperfusion injury is a paradoxical medical problem where restoring blood flow to oxygen-starved tissues can actually worsen the damage already caused by lack of blood supply. This seemingly contradictory process affects multiple organs and can turn a medical emergency into an even more serious health crisis.

Table of contents

• What Is Reperfusion Injury?
• Other Names for This Condition
• When Does Reperfusion Injury Occur?
• Organs and Tissues Affected
• How Reperfusion Injury Happens
• The Ischemia Phase
• The Reperfusion Phase
• The Importance of Timing
• Key Biological Mechanisms
• Consequences and Complications

What Is Reperfusion Injury?

Reperfusion injury is defined as the paradoxical worsening of cell damage and death that occurs when blood flow is restored to tissues that have been deprived of oxygen and nutrients. While reestablishing blood flow is essential to save oxygen-starved tissues, the return of circulation can paradoxically cause additional harm, threatening both the function and survival of the affected organ.^[1]

This phenomenon occurs when blood supply returns to tissue after a period of ischemia (reduced blood flow), anoxia (complete lack of oxygen), or hypoxia (reduced oxygen levels). The absence of oxygen and nutrients during the ischemic period creates conditions where the restoration of circulation triggers inflammation and oxidative damage (damage caused by highly reactive oxygen molecules) rather than simply restoring normal function.^[2]

ischemia-reperfusion injury, IRI, reoxygenation injury, reperfusion insult

Other Names for This Condition

Medical professionals may refer to reperfusion injury using several different terms. The condition is also known as ischemia-reperfusion injury, commonly abbreviated as IRI. Some sources call it reoxygenation injury or reperfusion insult.^[2][3]

When Does Reperfusion Injury Occur?

Reperfusion injury is a common problem in emergency medicine and surgery. It occurs in situations where blood supply is restored after a period of reduced or blocked circulation. Common scenarios include treatment after heart attacks, strokes, traumatic injuries, organ transplants, and certain surgical procedures.^[3]

The injury happens most often when blood flow is cut off by a blood clot, a blockage in a blood vessel, or massive blood loss. The first line of treatment in these situations is typically thrombolytic therapy (medication that dissolves blood clots) or an invasive procedure to restore blood flow. However, after this restoration of circulation, additional damage can occur to cells and their membranes. This is sometimes called the “second hit” phenomenon.^[3]

Reperfusion injury plays a major role in the biochemistry of brain injury in stroke and in brain damage following reversal of cardiac arrest. It is also a primary concern in liver transplantation surgery. Additionally, repeated cycles of ischemia and reperfusion injury are thought to contribute to the formation and failure to heal of chronic wounds such as pressure sores and diabetic foot ulcers. Continuous pressure limits blood supply and causes ischemia, while inflammation occurs during reperfusion. As this process repeats, it eventually damages tissue enough to cause a wound.^[2][6]

Organs and Tissues Affected

• Heart
• Brain
• Lungs
• Kidneys
• Liver
• Skeletal muscle
• Gut (intestines)

Reperfusion injury can occur in a wide range of organs. The most commonly affected organs include the heart, brain, lungs, kidneys, liver, skeletal muscle, and gut. The damage may involve not only the ischemic organ itself but can also trigger systemic inflammation that spreads to distant organs, potentially leading to multi-system organ failure.^[1][3]

How Reperfusion Injury Happens

Reperfusion injury is a complex process involving extensive tissue destruction through multiple biological pathways. Understanding this process requires looking at what happens during both the ischemia phase and the reperfusion phase.^[1]

The Ischemia Phase

During ischemia, when blood supply is less than what is needed for normal function, tissues become deficient in oxygen, glucose, and other substances required for normal cell metabolism. Metabolic problems begin during this ischemic phase itself.^[1]

Initially, cells break down stored glycogen through a process called anaerobic glycolysis, which produces small amounts of adenosine triphosphate (ATP, the cell’s energy currency) along with lactic acid. This lactic acid causes tissue pH to drop, making the environment more acidic, which then inhibits further ATP production. ATP is then broken down step by step into other molecules including adenosine, inosine, hypoxanthine, and xanthine.^[1]

At the cellular level, the lack of ATP causes ATP-dependent ionic pumps to fail. These pumps normally maintain the proper balance of ions inside and outside cells. When they fail, sodium accumulates inside cells, drawing water with it to maintain osmotic balance, causing cells to swell. Potassium escapes from cells into the surrounding fluid. Calcium is released from cellular structures called mitochondria into the cytoplasm and extracellular spaces.^[1]

The rising calcium levels activate enzymes that convert a cellular enzyme called xanthine dehydrogenase into xanthine oxidase. Other enzymes called phospholipases are also activated during ischemia, breaking down membrane lipids and increasing levels of circulating fatty acids. Additionally, ischemia induces the expression of a large number of genes that play a major role in how tissues respond to ischemic damage.^[1]

The Reperfusion Phase

The main reason for the acute phase of ischemia-reperfusion injury is oxygen deprivation during ischemia, followed by the sudden return of oxygen during reperfusion when the injury is actually enhanced. The sudden increase in blood and oxygen flow triggers the activation of inflammatory processes, release of signaling molecules called cytokines (proteins that regulate immune responses), and results in further damage to cells and their membranes.^[2][3]

During ischemia, a substance called succinate accumulates to very high levels. When oxygen returns during reperfusion, mitochondria in cells can undergo a process called reverse electron transfer. This results in the production of reactive oxygen species (ROS), which are highly reactive molecules containing oxygen that can damage cells.^[2]

The mechanisms of reperfusion injury involve three main processes: increased formation of reactive oxygen species, problems with tiny blood vessels called microvessels, and activation of the inflammatory response.^[3]

The Importance of Timing

The severity of reperfusion injury is directly related to how long ischemia lasts. Studies have shown that patients receiving thrombolytic therapy within one hour experienced a 51% reduction in infarct size (amount of damaged tissue) compared to only a 31% reduction in those receiving treatment after one to two hours.^[3]

Every minute counts when treating ischemia. Research shows that during a stroke, the brain loses approximately 1.9 million neurons, 14 billion connections, and 12 kilometers of nerve fibers every minute without intervention. Every hour of stroke damage is equivalent to about 3.6 years of normal brain aging.^[13]

The main concern remains that early restoration of blood flow should be achieved to prevent extensive initial cellular damage. However, this must be balanced against the risk of reperfusion injury that comes with restoring circulation.^[3]

Key Biological Mechanisms

Multiple pathological processes are involved in reperfusion injuries. These include cell damage through various forms of cell death (apoptosis, necrosis, and ferroptosis), oxidative stress, inflammatory response, breakdown of protective barriers like the blood-brain barrier, changes in the extracellular matrix (the structural network surrounding cells), formation of new blood vessels, enlargement of heart muscle cells, and tissue scarring called fibrosis.^[4]

Mitochondrial complex I, a key component of cellular energy production, is thought to be the most vulnerable enzyme to tissue ischemia and reperfusion. During ischemia, lack of oxygen leads to conditions where this enzyme loses its natural helper molecule called flavin mononucleotide and becomes inactive. The returning oxygen during reperfusion then triggers the production of damaging reactive oxygen species.^[2]

The process results in activation of white blood cells, triggering of inflammatory pathways, and damage to blood vessel walls and protective barriers. All of these contribute to the cascade of damage that characterizes reperfusion injury.^[1]

Consequences and Complications

Return of spontaneous circulation is achieved in 20 to 40% of out-of-hospital cardiac arrests where resuscitation is attempted. For these patients, reperfusion injury is responsible for increased death rates in the hospital, and consequently only 40 to 50% of them survive to be discharged from the hospital. Moreover, survivors frequently have persistent subtle cognitive impairment, and some have severe neurological deficits. Some patients also develop persistent heart failure.^[14]

Rates of bleeding in the brain after a stroke are generally higher with certain reperfusion treatments. Symptomatic bleeding inside the skull occurs in approximately 6.4% to 10% of patients receiving clot-dissolving medications, and in 2% to 4% of patients receiving mechanical removal of the clot.^[3]

Reperfusion can cause hyperkalemia, which is an abnormally high level of potassium in the blood. In patients with critical limb ischemia who undergo restoration of blood flow to the foot, increased pain and swelling attributed to reperfusion may occur. In the calf, severe reperfusion injury may result in compartment syndrome, a serious condition where pressure builds up within muscles. While compartment syndrome in the foot has not been well described, it could theoretically occur.^[2][9]

In patients with critical limb ischemia, reperfusion syndrome after revascularization is not well described but occurs in less than 10% of patients based on clinical experience. It is generally self-limited, often resolving within one week after revascularization. Treatment is generally supportive, with pain managed using non-steroidal anti-inflammatory medications and swelling controlled with compression stockings when there is adequate skin blood flow.^[9]

Reperfusion injury can also induce systemic inflammation, potentially leading to multi-organ failure. Therapeutic strategies developed to improve cardiac arrest survival may be successful in terms of increased survival but are often limited by the increased rate of reperfusion injury associated with prolonged cardiopulmonary resuscitation.^[3][14]